Systematic review of pregnancy and renal outcomes for women with chronic kidney disease receiving assisted reproductive therapy.
Chronic kidney disease
Fertility treatment
Fetal outcomes
Pregnancy
Journal
Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
28
06
2022
accepted:
19
10
2022
pubmed:
18
11
2022
medline:
30
11
2022
entrez:
17
11
2022
Statut:
ppublish
Résumé
As awareness around infertility is increasing among patients with chronic kidney disease (CKD), ever more of them are seeking Assisted Reproductive Technology (ART). Our aim was to perform a systematic review to describe obstetric and renal outcomes in women with CKD following ART. The following databases were searched from 1946 to May 2021: (1) Cochrane Central Register of Controlled Trials (CENTRAL), (2) Cumulative Index to Nursing and Allied Health Literature (CINAHL), (3) Embase and (4) MEDLINE. The database search identified 3520 records, of which 32 publications were suitable. A total of 84 fertility treatment cycles were analysed in 68 women. Median age at time of pregnancy was 32.5 years (IQR 30.0, 33.9 years). There were 60 clinical pregnancies resulting in 70 live births (including 16 multifetal births). Four women developed ovarian hyperstimulation syndrome which were associated with acute kidney injury. Hypertensive disorders complicated 26 pregnancies (38.3%), 24 (35.3%) pregnancies were preterm delivery, and low birth weight was present in 42.6% of pregnancies. Rates of live birth and miscarriage were similar for women with CKD requiring ART or having natural conception. However, more women with ART developed pre-eclampsia (p < 0.05) and had multifetal deliveries (p < 0.001), furthermore the babies were lower gestational ages (p < 0.001) and had lower birth weights (p < 0.001). This systematic review represents the most comprehensive assessment of fertility outcomes in patients with CKD following ART. However, the high reported live birth rate is likely related to reporting bias. Patient selection remains crucial in order to maximise patient safety, screen for adverse events and optimise fertility outcomes.
Sections du résumé
BACKGROUND
As awareness around infertility is increasing among patients with chronic kidney disease (CKD), ever more of them are seeking Assisted Reproductive Technology (ART). Our aim was to perform a systematic review to describe obstetric and renal outcomes in women with CKD following ART.
METHODS
The following databases were searched from 1946 to May 2021: (1) Cochrane Central Register of Controlled Trials (CENTRAL), (2) Cumulative Index to Nursing and Allied Health Literature (CINAHL), (3) Embase and (4) MEDLINE.
RESULTS
The database search identified 3520 records, of which 32 publications were suitable. A total of 84 fertility treatment cycles were analysed in 68 women. Median age at time of pregnancy was 32.5 years (IQR 30.0, 33.9 years). There were 60 clinical pregnancies resulting in 70 live births (including 16 multifetal births). Four women developed ovarian hyperstimulation syndrome which were associated with acute kidney injury. Hypertensive disorders complicated 26 pregnancies (38.3%), 24 (35.3%) pregnancies were preterm delivery, and low birth weight was present in 42.6% of pregnancies. Rates of live birth and miscarriage were similar for women with CKD requiring ART or having natural conception. However, more women with ART developed pre-eclampsia (p < 0.05) and had multifetal deliveries (p < 0.001), furthermore the babies were lower gestational ages (p < 0.001) and had lower birth weights (p < 0.001).
CONCLUSION
This systematic review represents the most comprehensive assessment of fertility outcomes in patients with CKD following ART. However, the high reported live birth rate is likely related to reporting bias. Patient selection remains crucial in order to maximise patient safety, screen for adverse events and optimise fertility outcomes.
Identifiants
pubmed: 36396849
doi: 10.1007/s40620-022-01510-x
pii: 10.1007/s40620-022-01510-x
pmc: PMC9700651
doi:
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2227-2236Informations de copyright
© 2022. The Author(s).
Références
JAMA. 2019 Jan 15;321(2):205-207
pubmed: 30644975
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Fertil Steril. 2017 Sep;108(3):393-406
pubmed: 28760517
Hum Fertil (Camb). 2004 Jun;7(2):127-33
pubmed: 15223762
Ups J Med Sci. 2020 May;125(2):152-157
pubmed: 32101068
Reprod Biomed Online. 2019 Feb;38(2):133-137
pubmed: 30593441
Am J Obstet Gynecol. 2021 Sep;225(3):298.e1-298.e20
pubmed: 33823152
Am J Transplant. 2011 Nov;11(11):2388-404
pubmed: 21794084
Hum Reprod. 1995 Jun;10(6):1528-30
pubmed: 7593529
PLoS One. 2013;8(2):e56583
pubmed: 23437176
Hum Reprod. 2020 Dec 1;35(12):2725-2734
pubmed: 33252685
Hum Reprod. 2007 Apr;22(4):1073-9
pubmed: 17251357
Br J Obstet Gynaecol. 1997 Oct;104(10):1106-7
pubmed: 9332984
Hum Reprod. 2015 Jan;30(1):205-13
pubmed: 25376456
Nat Rev Dis Primers. 2019 Jan 24;5(1):7
pubmed: 30679436
J Am Soc Nephrol. 2015 Aug;26(8):2011-22
pubmed: 25766536
Nephrol Dial Transplant. 1992;7(4):279-87
pubmed: 1317516
BMC Nephrol. 2019 Jan 23;20(1):24
pubmed: 30674290
Nephrol Dial Transplant. 2021 Nov 9;36(11):2008-2017
pubmed: 33313680
Oncologist. 2007 Jan;12(1):20-37
pubmed: 17227898
Nat Rev Nephrol. 2018 Mar;14(3):165-184
pubmed: 29355168
Am J Kidney Dis. 1997 May;29(5):685-90
pubmed: 9159301
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin J Am Soc Nephrol. 2013 Feb;8(2):290-8
pubmed: 23085724
JAMA. 2021 Jul 06;326(1):65-76
pubmed: 34228062